ORTX insider transaction filings
Orchard Therapeutics plc — 9 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-01-24. Screen ORTX transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for ORTX between 2026-06-21 and 2026-09-19. The table below lists the most recent filings on record.
Recent Form 4 filings — Orchard Therapeutics plc
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-01-24 | 4 | Beck Joanne T. — Director | Disposition to issuer (D): 9,294 · Disposition to issuer (D): 46,000 (derivative) @ $0 · Disposition to issuer (D): 105,000 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Gaspar Bobby — Chief Executive Officer, Director | Disposition to issuer (D): 366,158 · Disposition to issuer (D): 597,860 (derivative) @ $0 · Disposition to issuer (D): 40,010 (derivative) @ $0 · Disposition to issuer (D): 96,420 (derivative) @ $0 · Disposition to issuer (D): 50,000 (derivative) @ $0 · Disposition to issuer (D): 200,000 (derivative) @ $0 · +7 more | EDGAR |
| 2024-01-24 | 4 | Dunoyer Marc — Director | Disposition to issuer (D): 37,179 · Disposition to issuer (D): 80,030 (derivative) @ $0 · Disposition to issuer (D): 46,000 (derivative) @ $0 · Disposition to issuer (D): 105,000 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Curnutte John T — Director | Disposition to issuer (D): 46,000 (derivative) @ $0 · Disposition to issuer (D): 105,000 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Rowland Charles A Jr — Director | Disposition to issuer (D): 12,294 · Disposition to issuer (D): 46,000 (derivative) @ $0 · Disposition to issuer (D): 105,000 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Altschuler Steven — Director | Disposition to issuer (D): 46,000 (derivative) @ $0 · Disposition to issuer (D): 105,000 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Secor Alicia — Director | Disposition to issuer (D): 46,000 (derivative) @ $0 · Disposition to issuer (D): 105,000 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | THOMAS FRANK E — See Remarks | Disposition to issuer (D): 92,081 · Disposition to issuer (D): 99,980 (derivative) @ $0 · Disposition to issuer (D): 199,990 (derivative) @ $0 · Disposition to issuer (D): 149,990 (derivative) @ $0 · Disposition to issuer (D): 309,990 (derivative) @ $0 · Disposition to issuer (D): 27,730 (derivative) @ $0 · +5 more | EDGAR |
| 2024-01-24 | 4 | GERAGHTY JAMES A — Director | Disposition to issuer (D): 44,391 · Disposition to issuer (D): 46,000 (derivative) @ $0 · Disposition to issuer (D): 105,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Orchard Therapeutics plc
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-01-24 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ORTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →